ENTACAPONE and DEATH

Overview

DEATH is the #5 most commonly reported adverse reaction for ENTACAPONE, manufactured by Ajanta Pharma USA Inc.. There are 318 FDA adverse event reports linking ENTACAPONE to DEATH. This represents approximately 2.8% of all 11,238 adverse event reports for this drug.

Patients taking ENTACAPONE who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DEATH is a less commonly reported adverse event for ENTACAPONE, but still significant enough to appear in the safety profile.

Other Side Effects of ENTACAPONE

In addition to death, the following adverse reactions have been reported for ENTACAPONE:

• DYSKINESIA — 461 reports
• HALLUCINATION — 459 reports
• FALL — 443 reports
• DRUG INEFFECTIVE — 332 reports
• PARKINSON^S DISEASE — 274 reports
• CONFUSIONAL STATE — 255 reports
• GAIT DISTURBANCE — 253 reports
• TREMOR — 251 reports
• ON AND OFF PHENOMENON — 225 reports
• SOMNOLENCE — 190 reports

Other Drugs Associated with DEATH

The following drugs have also been linked to death in FDA adverse event reports:

Does ENTACAPONE cause DEATH?

DEATH has been reported as an adverse event in 318 FDA reports for ENTACAPONE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DEATH with ENTACAPONE?

DEATH accounts for approximately 2.8% of all adverse event reports for ENTACAPONE, making it a notable side effect.

What should I do if I experience DEATH while taking ENTACAPONE?

If you experience death while taking ENTACAPONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages